Pneumonia is an infection of the tissue in the lung. It can range from mild to fatal, depending on the type of germ causing the infection, your age, and your overall health.
Pneumonia is usually caused by a bacterial infection, but it can also be caused by a virus, such as coronavirus (COVID-19).
What is pneumonia?
What causes pneumonia?
Symptoms of pneumonia
Treatment for pneumonia
Our pneumonia research
Hudson Institute researchers are nationally and internationally recognised for progressing our understanding of the immune system’s inflammatory response and developing new approaches to treat bacterial infections.
Our pneumonia researchers are building knowledge of how lung inflammation develops and discovering new and repurposing existing drugs that can be used to treat bacterial and viral pneumonia.
Tackling acute inflammation in COVID-19 and Influenza
Molecular studies, new treatment. Associate Professors Michelle Tate and Ashley Mansell are identifying the molecular processes behind viral lung inflammation and examining how COVID-19 and influenza virus infection results in severe lung inflammation and the development of pneumonia.
Using this knowledge, they are testing new and repurposed anti-inflammatory drugs that could be used to treat pneumonia in COVID-19 and severe influenza virus infections.
Controlling bacterial lung infection with innate immune molecules
Eliminating pathogenic bacteria to prevent pneumonia
- Walter and Eliza Hall Institute of Medical Research
- Australian National University
- Industry Partners Australia
- Monash BDI
- Monash Health
- University of Melbourne
- University of Hokkaido
- University of Saskatchewan
- Industry collaborators in Australia and the USA
Explore our labs
Support for people with Pneumonia
Hudson Institute scientists cannot provide medical advice.
Find out more about pneumonia.
Keep up-to-date with our latest discoveries